Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities

Clinical trial NCT00242814 · COMPLETED

Trial details

NCT number: NCT00242814
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension Metabolic Syndrome X

Start date: 2005-11-03
Primary completion: 2007-03-29
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.